|Awarded On||August 19, 2020|
|Title||Genetic Epidemiology of Hepatocellular Carcinoma in Hispanics|
|Award Mechanism||Collaborative Action Program to Reduce Liver Cancer Mortality in Texas: Investigator-Initiated Research Awards|
|Institution/Organization||Baylor College of Medicine|
|Principal Investigator/Program Director||Aaron Thrift|
|Cancer Sites||Gallbladder, Liver and Intrahepatic Bile Duct|
*Pending contract negotiation
Our goal is to reduce the death and suffering related to liver cancer in Texas, especially among minority populations. Hepatocellular carcinoma (HCC) is the most common (>90%) of liver cancers. HCC has the fastest increasing cancer-related mortality rate among all solid tumors in the U.S., and is particularly important for Texas residents. Texas has the highest incidence rate for HCC in the nation. Hispanics are disproportionately affected by HCC, surpassing Asians and Pacific Islanders as the racial/ethnic group at highest risk for HCC. The disparity is even more pronounced among Hispanics living in South Texas and U.S./Mexico border regions. Most cases of HCC (>90%) arise in the back...